Number of Pradaxa® Lawsuits on the Rise
Since May of this year, 470 new Pradaxa® lawsuits have been added to the Multidistrict Litigation In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385), which is currently pending in the United States District Court for the Southern District of Illinois before the Honorable Chief Judge David R. Herndon. The number of lawsuits joined in MDL 2385 increased from 663 in May 2013 to 1,133 as of July 10, 2013.
The rising number of such lawsuits is indicative of the serious injuries that individuals have sustained while taking Pradaxa®, an oral anticoagulant manufactured by Boehringer Ingelheim Pharmaceuticals that has been linked to severe internal bleeding. The first bellwether trial in MDL 2385 is set for August 2014.
Schlichter, Bogard & Denton, LLP are leaders in the national Multidistrict Litigation against the makers of Pradaxa®. Roger Denton has been appointed by Judge Herndon to serve as Plaintiffs’ Co-Lead Counsel in the Multidistrict Litigation.
If you or a loved one have experienced complications from Pradaxa®, please contact the experienced attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.